IGF2BP2 and fatty liver disease: In agreement with the observations in the HFHC mice, knockdown of IGF2BP2 also substantially ameliorate hepatic steatosis, liver inflammation, and fibrosis in MCD diet-induced NASH mice (Supplementary Fig. S3a–f).